Bukwang Pharmaceutical Co (XKRX:003000) Net Change in Cash : ₩-74,646 Mil (TTM As of Mar. 2025)

View and export this data going back to 1988. Start your Free Trial

What is Bukwang Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Bukwang Pharmaceutical Co's Net Change in Cash for the three months ended in Mar. 2025 was ₩-2,278 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-74,646 Mil.

Bukwang Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Bukwang Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bukwang Pharmaceutical Co Net Change in Cash Chart

Bukwang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

41,705.97

3,486.36

2,739.61

65,710.43

-61,136.04

Bukwang Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															11,232.25	-53,252.42	8,390.57	-27,506.44	-2,277.71

Bukwang Pharmaceutical Co Net Change in Cash Calculation

Bukwang Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	34361.977	+	-27727.116	+	-67650.882	+	-120.021
	=	-61,136

Bukwang Pharmaceutical Co's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 7244.498 + -8487.912 + -995.138 + -39.155

= -2,278

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-74,646 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bukwang Pharmaceutical Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Bukwang Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Bukwang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bukwang Pharmaceutical Co Ltd (XKRX:003000) » Definitions » Net Change in Cash

Comparable Companies

XKRX:389470 XKRX:476060 XKRX:000520 XKRX:256840 XKRX:067080 XKRX:033270 XKRX:243070 XKRX:003220 XKRX:176750 XKRX:007570 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

N/A

Address

398-1 Daebang-Dong, Dongjak-Gu, Seoul, KOR

Website

http://www.bukwang.co.kr

Bukwang Pharmaceutical Co Ltd manufactures and markets medicines for diabetes, hepatitis B, anticancer and psychiatry. The Company's OTC products focus on dental treatment. The company also engages in venture business and bio engineering.

Bukwang Pharmaceutical Co Headlines

No Headlines